Evidence map›Paper›PMID 24786098›Full record

ReviewInternational journal of molecular sciences2014

Potential for layered double hydroxides-based, innovative drug delivery systems.

Kai Zhang, Zhi Ping Xu, Ji Lu, Zhi Yong Tang, Hui Jun Zhao, David A Good, Ming Qian Wei

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 115 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. USH2A Gene Editing Using the CRISPR System.Molecular therapy. Nucleic acids · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Kai ZhangSchool of Medical Science & Griffith Health Institute, Gold Coast Campus, Griffith University, Southport, QLD 4222, Australia. kai.zhang4@griffithuni.edu.au.
Zhi Ping XuAustralian Institutes for Bioengineering & Nanotechnology, University of Queensland, St Lucia, QLD 4072, Australia. gordonxu@uq.edu.au.
Ji LuAustralian Institutes for Bioengineering & Nanotechnology, University of Queensland, St Lucia, QLD 4072, Australia. ji.lu@uqconnect.edu.au.
Zhi Yong TangNational Centre for Nanoscience and Technology, Chinese Academy of Sciences, Beijing 100190, China. h.zhao@griffith.edu.au.
Hui Jun ZhaoGriffith Schools of Environment, Gold Coast Campus, Griffith University, Southport, QLD 4222, Australia. h.zhao@griffith.edu.au.
David A GoodSchool of Medical Science & Griffith Health Institute, Gold Coast Campus, Griffith University, Southport, QLD 4222, Australia. kai.zhang4@griffithuni.edu.au.
Ming Qian WeiSchool of Medical Science & Griffith Health Institute, Gold Coast Campus, Griffith University, Southport, QLD 4222, Australia. m.wei@griffithuni.edu.au.
Griffith University · AUThe University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Layered Double Hydroxides (LDHs)-based drug delivery systems have, for many years, shown great promises for the delivery of chemical therapeutics and bioactive molecules to mammalian cells in vitro and in vivo. This system offers high efficiency and drug loading density, as well as excellent protection of loaded molecules from undesired degradation. Toxicological studies have also found LDHs to be biocompatible compared with other widely used nanoparticles, such as iron oxide, silica, and single-walled carbon nanotubes. A plethora of bio-molecules have been reported to either attach to the surface of or intercalate into LDH materials through co-precipitation or anion-exchange reaction, including amino acid and peptides, ATPs, vitamins, and even polysaccharides. Recently, LDHs have been used for gene delivery of small molecular nucleic acids, such as antisense, oligonucleotides, PCR fragments, siRNA molecules or sheared genomic DNA. These nano-medicines have been applied to target cells or organs in gene therapeutic approaches. This review summarizes current progress of the development of LDHs nanoparticle drug carriers for nucleotides, anti-inflammatory, anti-cancer drugs and recent LDH application in medical research. Ground breaking studies will be highlighted and an outlook of the possible future progress proposed. It is hoped that the layered inorganic material will open up new frontier of research, leading to new nano-drugs in clinical applications.

Indexed as

AnimalsAnti-Inflammatory AgentsAntineoplastic AgentsDrug CarriersDrug Delivery SystemsGene Transfer TechniquesHumansHydroxidesNanoparticlesNeoplasmsOligonucleotidesAnti-Inflammatory AgentsAntineoplastic AgentsDrug CarriersHydroxidesOligonucleotides

Identifiers

PMID24786098
PMCPMC4057680
OpenAlexW2110333816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.